United Therapeutics publishes positive TETON-2 results in NEJM

March 11, 2026 6:14 PM

United Therapeutics Corporation (NASDAQ: UTHR) announced that The New England Journal of Medicine published full results from its phase 3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found